Search

everythinglearnresearchcommunity

for

Search:↓

Patients with advanced breast cancer prioritize quality of life, overall survival, and progression-free survival in treatment decisions.

Cepharanthine effectively reduces Herpes Simplex Virus Type 1 by blocking certain cell pathways and promoting cell death.

Combining baricitinib with low-dose corticosteroids significantly improved severe hair loss in eight patients.

The QuantAnts machines can find cancer markers and create CRISPR targets for them.

Bicalutamide, a drug with a good safety profile, is a promising new treatment for female pattern hair loss.

A woman developed severe bladder inflammation after cancer treatment with Cytoxan.

Temozolomide can cause severe bone marrow suppression, leading to life-threatening complications.

Radiation therapy successfully treated an elderly man's skin cancer and pre-cancerous scalp lesions.

Radiation therapy successfully treated an elderly man's skin cancer and pre-cancerous scalp lesions.

Tofacitinib improved hair regrowth and quality of life in children with alopecia areata, with mild side effects.

Topical vitamin D3 does not prevent hair loss from chemotherapy.

Skin side effects from cancer drugs targeting EGFR can affect treatment adherence but can be managed with antibiotics like tetracycline.

Baricitinib is effective and safe for treating severe alopecia areata for up to 5 years.

XMU-MP-1 stops cell growth in a human mini-organ and reduces the effectiveness of the chemotherapy drug paclitaxel.

Many patients on new leukemia drugs had mild to moderate skin reactions.

Ritlecitinib is generally safe for adolescents with alopecia areata over 5 years.

Baricitinib is effective and safe for treating severe alopecia areata with ongoing use.

A woman died from cancer that spread from a long-standing cyst on her abdomen.

Enobosarm may effectively treat androgen receptor-positive breast cancer with fewer side effects.

Palliative chemotherapy is cost-effective for advanced gastric and colorectal cancer but not clearly for pancreatic-biliary cancer.

Targeted cancer therapies often cause skin side effects, needing dermatologist care.

Neoadjuvant chemotherapy followed by surgery leads to fewer severe complications and better quality of life than immediate surgery in advanced ovarian cancer patients with high tumor load.

Targeting multiple pathways and understanding genetic mutations are crucial for effective melanoma therapy.

Tofacitinib may effectively regrow hair in alopecia totalis patients.

Baricitinib helps regrow hair in teens with severe alopecia areata.

The treatment showed significant hair regrowth in alopecia areata patients without side effects.

Ponatinib can cause a rare skin reaction that resolves with topical treatment and temporary drug discontinuation.

Baicapil was effective in reducing hair loss and increasing hair growth in women with telogen effluvium.

Semecarpus anacardium leaf extracts may offer safe, effective cancer treatment alternatives.

Ocoxin improves quality of life for advanced ovarian cancer patients on chemotherapy.